Researcher Profiles

Return to member profile

Susan Goodin, PharmD

Publications since 2011

Chen, X. Liu, Y. Wu, J. Huang, H. DU, Z. Zhang, K. Zhou, D. Hung, K. Goodin, S. Zheng, X. I. Mechanistic Study of Inhibitory Effects of Atorvastatin and Docetaxel in Combination on Prostate Cancer. Cancer Genomics Proteomics, 13:151-160, . (PMID: 26912805)

Goodin, S. Barbour, S. Song, J. Berrak, E. Cox, D. Safety and tolerability of eribulin mesylate in patients with pretreated metastatic breast cancer. Am J Health Syst Pharm, 72:2150-2156, . (PMID: 26637514)

Stein, M. N. Hussain, M. Stadler, W. M. Liu, G. Tereshchenko, I. V. Goodin, S. Jeyamohan, C. Kaufman, H. L. Mehnert, J. DiPaola, R. S. A Phase II Study of AT-101 to Overcome Bcl-2-Mediated Resistance to Androgen Deprivation Therapy in Patients With Newly Diagnosed Castration-Sensitive Metastatic Prostate Cancer. Clin Genitourin Cancer, In process, . (PMID: 26476589)

Goldspiel, B. Hoffman, J. M. Griffith, N. L. Goodin, S. DeChristoforo, R. Montello, C. M. Chase, J. L. Bartel, S. Patel, J. T. ASHP Guidelines on Preventing Medication Errors with Chemotherapy and Biotherapy. Am J Health Syst Pharm, 72:e6-e35, . (PMID: 25825193)

Huang, H. Chen, S. Van Doren, J. Li, D. Farichon, C. He, Y. Zhang, Q. Zhang, K. Conney, A. H. Goodin, S. Du, Z. Zheng, X. alpha-tomatine inhibits growth and induces apoptosis in HL-60 human myeloid leukemia cells. Mol Med Rep, In process, . (PMID: 25625536)

Huang, H. Chen, X. Li, D. He, Y. Li, Y. Du, Z. Zhang, K. DiPaola, R. Goodin, S. Zheng, X. Combination of alpha-Tomatine and Curcumin Inhibits Growth and Induces Apoptosis in Human Prostate Cancer Cells. PLoS One, 10:e0144293, . (PMID: 26630272)

Richie, J. P. Das, A. Calcagnotto, A. Sinha, R. Neidig, W. Liao, J. Lengerich, E. J. Berg, A. Hartman, T. J. Ciccarella, A. Baker, A. Kaag, M. G. Goodin, S. DiPaola, R. S. El-Bayoumy, K. Comparative effects of two different forms of selenium on oxidative stress biomarkers in healthy men: a randomized clinical trial. Cancer Prev Res (Phila), 7:796-804, . (PMID: 24938534, PMCID: PMC4125492)

Huang, H. Cui, X. X. Chen, S. Goodin, S. Liu, Y. He, Y. Li, D. Wang, H. VAN Doren, J. Dipaola, R. S. Conney, A. H. Zheng, X. Combination of Lipitor and Celebrex Inhibits Prostate Cancer VCaP Cells In Vitro and In Vivo. Anticancer Res, 34:3357-3363, . (PMID: 24982340)

Wang, H. Cui, X. X. Goodin, S. Ding, N. Van Doren, J. Du, Z. Huang, M. T. Liu, Y. Cheng, X. Dipaola, R. S. Conney, A. H. Zheng, X. Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib. Oncol Rep, 31:835-841, . (PMID: 24296978, PMCID: PMC3981114)

Goodin, S. Dipaola, R. S. Cabozantinib in Prostate Cancer: The Beginning of a Precision Paradigm? J Clin Oncol, 31:401-403, . (PMID: 23248244)

Ha, Y. S. Goodin, S. Dipaola, R. S. Kim, I. Y. Enzalutamide for the treatment of castration-resistant prostate cancer. Drugs Today (Barc), 49:7-13, . (PMID: 23362491)

Gounder, M. K. Lin, H. Stein, M. Goodin, S. Bertino, J. R. Kong, A. N. DiPaola, R. S. A validated bioanalytical HPLC method for pharmacokinetic evaluation of 2-deoxyglucose in human plasma. Biomed Chromatogr, 26:650-654, . (PMID: 21932382)

Stein, M. Goodin, S. Doyle-Lindrud, S. Silberberg, J. Kane, M. Metzger, D. Eddy, S. Shih, W. DiPaola, R. S. Transdermal estradiol in castrate and chemotherapy resistant prostate cancer. Med Sci Monit, 18:CR260-CR264, . (PMID: 22460098)

Stein, M. N. Goodin, S. Dipaola, R. S. Abiraterone in prostate cancer: a new angle to an old problem. Clin Cancer Res, 18:1848-1854, . (PMID: 22451619)

Goodin, S. Griffith, N. Chen, B. Chuk, K. Daouphars, M. Doreau, C. Patel, R. A. Schwartz, R. Tames, M. J. Terkola, R. Vadnais, B. Wright, D. Meier, K. Safe Handling of Oral Chemotherapeutic Agents in Clinical Practice: Recommendations From an International Pharmacy Panel. J Oncol Pract, 7:7-12, . (PMID: 21532802, PMCID: PMC3014516)

Zheng, X. Cui, X. X. Khor, T. O. Huang, Y. Dipaola, R. S. Goodin, S. Lee, M. J. Yang, C. S. Kong, A. N. Conney, A. H. Inhibitory Effect of a gamma-Tocopherol-Rich Mixture of Tocopherols on the Formation and Growth of LNCaP Prostate Tumors in Immunodeficient Mice. Cancers (Basel), 3:3762-3772, . (PMID: 24213110, PMCID: PMC3763395)